Work

Post‐authorization safety study of Clottafact®, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study

Year: 2016

Type: article

Study design: Observational Study

Source: Vox Sanguinis

DOI: 10.1111/vox.12424

Authors: C. Négrier, C. Rothschild, J.‐Y. Borg, T. Lambert, S. Claeyssens, L. Sanhes, N. Stieltjes, A. Bertrand, M.‐H. André, P. Sié, Y. Gruel, Z. Tellier

Institutions: Hôpital Edouard Herriot, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Hôpital Charles-Nicolle, Bicêtre Hospital, Hôpital Purpan, Centre Hospitalier de Perpignan, Hôpital Cochin, LFB (France), Hôpital Rangueil

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2514944509

FWCI: 1.585

Cites: 17

Cited by: 19

Related to: 10